Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
China Argricultural University currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, HUDSON, AMY ROSE, who is the busiest examiner with 1 pending action. The activity is confined to 1 distinct art unit. This 1 to 1 ratio between the pending action, the examiner, and the art unit indicates a very specific and narrow prosecution profile. With only 1 pending office action, the company's entire active presence at the patent office is concentrated in this one matter.
Practitioners must focus their strategy on the individual preferences of HUDSON, AMY ROSE, as there are no other examiners involved in the portfolio to provide a broader perspective. The concentration in 1 distinct art unit within the Biotechnology & Pharmaceuticals field suggests that the technology is specialized. Because there is only 1 pending action, every procedural step is critical to the company's intellectual property goals. The prosecution team should focus on the specific guidelines of the 1 assigned art unit to ensure that this single matter proceeds efficiently. The outcome of this 1 pending office action will be the sole indicator of the company's current success in patent acquisition.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUDSON, AMY ROSE | 1 | 74.9% | +11.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19306912 | CRISPR/CAS EFFECTOR PROTEIN AND SYSTEM | HUDSON, AMY ROSE | — |
| Art Unit | Apps |
|---|---|
| 1636 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19306912 | CRISPR/CAS EFFECTOR PROTEIN AND SYSTEM | HUDSON, AMY ROSE | 1636 | §112 | Non-Final OA | — | Pending | Aug 21, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial